Diploid & Genomenon team up to advance rare disease diagnostics
In a major effort to develop genome interpretation for the rare disease diagnostics, Genomenon, a…
FDA permits Priority Review for Roche’s drug Polatuzumab Vedotin
The FDA will decide on the definitive approval by the 19th of August 2019. The…
Glenmark Pharma seeks USFDA approval for generic skin treatment foam
Glenmark Pharmaceuticals, the Mumbai-headquartered pharmaceutical company, has made it to the front page for receiving…
Innovent, Chipscreen Biosciences team up on colorectal cancer therapy
Shenzhen Chipscreen Biosciences Ltd., a leading China-based integrated biotech company, has reportedly entered into a…
AbCellera to sign multi-target partnership deal with Novartis
AbCellera Biologics Inc., the antibody therapeutics developer based in Vancouver, has reportedly entered into a…
GrapheneCA plans graphene production for cosmetics & pharma sectors
Nano Graphene Inc. (also known as GrapheneCA), a US-based supplier of graphene-based materials, has reportedly…
GfK, SymphonyAI collaborate to advance digital research and innovation
GfK, Germany’s largest market research company, and SymphonyAI (SAI), a group of leading AI solution…
IBM & Boehringer Ingelheim to use blockchain in clinical recordkeeping
IBM is expected to offer blockchain technologies to make sure that transparency and trust are…
Auro Pharma seals buyout deal for Apotex’s operations in 5 EU states
The globally reputed Aurobindo Pharma, based in Hyderabad, has apparently made it to the front…